Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat

American Journal of Pathology

Volumn 149, Issue 6, 1996, Pages 2055-2066

  Pratt, Julian R ^a   Hibbs, Martin J ^b   Laver, Alison J ^b   Smith, Richard A G ^b   Sacks, Steven H ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT RECEPTOR; TP 10; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; DRUG EFFECT; DRUG EFFICACY; GRAFT SURVIVAL; IMMUNOREGULATION; INFLAMMATORY INFILTRATE; KIDNEY ALLOGRAFT REJECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ACUTE DISEASE; ANIMALS; COMPLEMENT C3; COMPLEMENT INACTIVATOR PROTEINS; COMPLEMENT MEMBRANE ATTACK COMPLEX; ENDOTHELIUM, VASCULAR; GRAFT REJECTION; GRAFT SURVIVAL; ISCHEMIA; KIDNEY TRANSPLANTATION; KINETICS; LEUKOCYTES; RATS; RATS, INBRED LEW; RECEPTORS, COMPLEMENT; SOLUBILITY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029852816     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunhill MS, Halloran PF, Hayry P, Jennette JC, Keown PA, Marcussen N, Mihatsch MJ, Morozumi K, Myers BD, Nast CC, Olsen S, Racusen LC, Ramos EL, Rosen S, Sachs DH, Salomon DR, Sanfillipo F, Verani R, von Willebrand E, Yamagushi Y: International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993, 44:411-422
2. d'Ardenne AJ, Dunnill MS, Thompson JF, McWhinnie D, Wood RF, Morris, PJ: Cyclosporin and renal graft histology, J Clin Pathol 1986, 39:145-151
3. Burdick JF, Beschorner WE, Smith WJ, McGraw D, Bender WL, Williams, GM, Solez K: Characteristics of early routine renal allograft biopsies. Transplantation 1984, 38:679-684
4. Neild GH, Taube DH, Hartley RB, Bignardi L, Cameron JS, Williams DG, Ogg CS, Rudge CJ: Morphological differentiation between rejection and cyclosporin nephrotoxicity in renal allografts. J Clin Pathol 1986, 39:152-159
5. Feucht HE, Felber E, Gokel MJ, Hillebrand G, Nattermann U, Brockmeyer, C, Held E, Riethmuller G, Land W, Albert E: Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 1991, 86:464-470
6. Kirschfink M, Wienert T, Rother K, Pomer S: Complement activation in renal allograft recipients. Transplant Proc 1992, 24:2556-2557
7. Arvieux J, Yssel H, Colomb MG. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology 1988, 65:229-235
8. Jacquier-Sarlin MR, Gabert FM, Villiers MB, Colomb MG: Modulation of antigen processing and presentation by covalently linked complement C3b fragment. Immunology 1995, 84:164-170
9. Erdei A, Spaeth E, Alsenz J, Rude E, Schulz T, Gergely J, Dierich, MP: Role of C3b receptors in the enhancement of interleukin-2-dependent T-cell proliferation. Mol Immunol 1984, 21:1215-1221
10. Pepys MB, Brighton WD, Hewitt BE, Bryant DE, Pepys J: Complement in the induction of IgE antibody formation. Clin Exp Immunol 1977, 27:397-400
11. Melchers F, Erdei A, Corbel C, Leptin M, Schulz T, Dierich MP: Cell cycle control of activated, synchronized murine B lymphocytes: roles of macrophages and complement C3. Mol Immunol 1986, 23:1173-1176
12. Tuveson DA, Ahearn JM, Matsumoto AK, Fearon DT: Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex. J Exp Med 1991, 173:1083-1089
13. Wiersma EJ, Kinoshita T, Heyman B: Inhibition of immunological memory and T-independent humoral responses by monoclonal antibodies specific for murine complement receptors. Eur J Immunol 1991, 21:2501-2506
14. Yoon SH, Fearon DT: Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma. J Immunol 1985, 134:3332-3338
15. Weisman HF, Bartow T, Leppo MK, Marsh HC Jr, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT: Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990, 249:146-151
16. Homeister JW, Satoh PS, Kilgore KS, Lucchesi BR: Soluble complement receptor type 1 prevents human complement-mediated damage of the rabbit isolated heart. J Immunol 1993, 150:1055-1064
17. Pruitt SK, Kirk AD, Bollinger RR, Marsh HC Jr, Collins BH, Levin JL, Mault JR, Heinle JS, Ibrahim S, Rudolph AR, Baldwin WM III, Sanfillipo F: The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994, 57:363-370
18. Pruitt SK, Bollinger RR: The effect of soluble complement receptor type 1 on hyperacute allograft rejection. J Surg Res 1991, 50:350-355
19. Fabre J, Lim SH, Morris PJ: Renal transplantation in the rat: details of a technique. Austr N Zealand J Surg 1971, 41:69-75
20. Kabat EA, Mayer J: Experimental Immunochemistry, ed 2. Charles C Thomas, Springfield, 1961, 133-240
21. Leventhal JR, Matas AJ, Sun LH, Reif S, Bolman RM III, Dalmasso AP, Platt JL: The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Transplantation 1993, 56:1-8
22. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981, 29:577-580
23. Pratt JR, Hibbs MJ, Laver AJ, Smith RAG, Sacks SH: Allograft immune response with sCR1 intervention. Transplant Immunol 1996, 4:72-75
24. Pruitt SK, Baldwin WM III, Marsh HC Jr, Lin SS, Yeh CG, Bollinger RR: The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 1991, 52:868-873
25. Xia W, Fearon DT, Moore FD Jr, Schoen FJ, Ortiz F, Kirkman RL: Prolongation of guinea pig cardiac xenograft survival in rats by soluble human complement receptor type 1. Transplant Proc 1992, 24:479-480
26. Cranston D, Wood KJ, Morris PJ: Splenectomy and renal allograft survival in the rat. Br J Surg 1988, 75: 18-22
27. Campbell AK, Morgan BP: Monoclonal antibodies demonstrate protection of polymorphonuclear leukocytes against complement attack. Nature 1985, 317: 164-166
28. Yancey KB, Lawley TJ, Dersookian M, Harvath L: Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: flow cytometric and chemotaxis studies. J Invest Dermatol 1989, 92:184-189
29. Piquette CA, Robinson-Hill R, Webster RO: Human monocyte chemotaxis to complement-derived chemotaxins is enhanced by Gc-globulin. J Leukocyte Biol 1994, 55:349-354
30. Erdei A, Kohler V, Schafer H, Burger R: Macrophage-bound C3 fragments as adhesion molecules modulate presentation of exogenous antigens. Immunobiology 1992, 185:314-326
31. van den Berg TK, Dopp EA, Daha MR, Kraal G, Dijkstra CD: Selective inhibition of immune complex trapping by follicular dendritic cells with monoclonal antibodies against rat C3. Eur J Immunol 1992, 22:957-962